The book is currently out of stock
Parameters
More about the book
From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M& A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M& A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.
Book purchase
Pharma m&a versus alliances and its underlying value drivers, Heiko Schon
- Language
- Released
- 2015
- product-detail.submit-box.info.binding
- (Hardcover)
We’ll email you as soon as we track it down.
Payment methods
No one has rated yet.